Studies have shown that individuals using Wegovy have experienced an average weight loss of 15-20% of their total body weight
For GLP-1s, common requirements include documented diet-and-exercise attempts (36 months), trials of older weight-loss medications (phentermine, orlistat, naltrexone-bupropion), or use of a preferred GLP-1 product over a non-preferred one
The result showed that AGEs could increase bone resorption by reducing OC and increasing CTX but liraglutide could significantly decrease AGEs and parathyroid hormone (PTH) in ApoE / mice (Zhang et al., 2019a)
What the Latest Clinical Trial Data Shows The TRIUMPH-4 trial, whose results Eli Lilly announced in December 2025, is the first completed Phase 3 study for retatrutide
If side effects become intolerable at a higher dose, your provider can reduce back to your previous dose or add supportive medications
Main P, Angley MT, O'Doherty CE, Thomas P, Fenech M